Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Genetic Polymorphisms in Drug Induced Neuropathy in Children With Acute Lymphoblastic Leukemia

NCT05811910 is registered in ClinicalTrials.gov with IRCCS Burlo Garofolo as lead sponsor.

NCT NCT05811910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05811910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Genetic Polymorphisms in Drug Induced Neuropathy in Children With Acute Lymphoblastic Leukemia
Lead sponsor
IRCCS Burlo Garofolo
Phase
Observational
Overall status
Unknown status
Start date
March 30, 2021
Completion date
December 31, 2023
Enrollment
290 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia